• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

主动监测作为新发前列腺癌的初始管理:来自 PURC 的数据。

Active Surveillance as Initial Management of Newly Diagnosed Prostate Cancer: Data from the PURC.

机构信息

Lewis Katz School of Medicine at Temple University , Philadelphia , Pennsylvania.

Geisinger Medical Center , Danville.

出版信息

J Urol. 2019 May;201(5):929-936. doi: 10.1016/j.juro.2018.10.018.

DOI:10.1016/j.juro.2018.10.018
PMID:30720692
Abstract

PURPOSE

We describe contemporary active surveillance utilization and variation in a regional prostate cancer collaborative. We identified demographic and disease specific factors associated with active surveillance in men with newly diagnosed prostate cancer.

MATERIALS AND METHODS

We analyzed data from the PURC (Pennsylvania Urologic Regional Collaborative), a cooperative effort of urology practices in southeastern Pennsylvania and New Jersey. We determined the rates of active surveillance among men with newly diagnosed NCCN® (National Comprehensive Cancer Network®) very low, low or intermediate prostate cancer and compared the rates among participating practices and providers. Univariate and multivariable analyses were used to identify factors associated with active surveillance utilization.

RESULTS

A total of 1,880 men met inclusion criteria. Of the men with NCCN very low or low risk prostate cancer 57.4% underwent active surveillance as the initial management strategy. Increasing age was significantly associated with active surveillance (p <0.001) while adverse clinicopathological variables were associated with decreased active surveillance use. Substantial variation in active surveillance utilization was observed among practices and providers.

CONCLUSIONS

More than 50% of men with low risk disease in the PURC collaborative were treated with active surveillance. However, substantial variation in active surveillance rates were observed among practices and providers in academic and community settings. Advanced age and favorable clinicopathological factors were strongly associated with active surveillance. Analysis of regional collaboratives such as the PURC may allow for the development of strategies to better standardize treatment in men with prostate cancer and offer active surveillance in a more uniform and systematic fashion.

摘要

目的

我们描述了一个区域性前列腺癌协作组中当代主动监测的使用情况和变化。我们确定了与新诊断前列腺癌患者接受主动监测相关的人口统计学和疾病特异性因素。

材料和方法

我们分析了 PURC(宾夕法尼亚州泌尿科区域协作)的数据,这是宾夕法尼亚州东南部和新泽西州泌尿科实践的合作努力。我们确定了新诊断的 NCCN(国家综合癌症网络®)极低、低或中危前列腺癌患者中接受主动监测的比例,并比较了参与实践和提供者之间的比例。使用单变量和多变量分析来确定与主动监测使用相关的因素。

结果

共有 1880 名男性符合纳入标准。在 NCCN 极低或低危前列腺癌患者中,57.4%的患者将主动监测作为初始管理策略。年龄的增加与主动监测显著相关(p <0.001),而不利的临床病理变量与主动监测使用减少相关。实践和提供者之间主动监测的使用存在很大差异。

结论

在 PURC 协作组中,超过 50%的低危疾病男性接受了主动监测。然而,在学术和社区环境中的实践和提供者之间,主动监测率存在很大差异。高龄和有利的临床病理因素与主动监测密切相关。对 PURC 等区域协作的分析可以制定更好地规范前列腺癌患者治疗的策略,并以更统一和系统的方式提供主动监测。

相似文献

1
Active Surveillance as Initial Management of Newly Diagnosed Prostate Cancer: Data from the PURC.主动监测作为新发前列腺癌的初始管理:来自 PURC 的数据。
J Urol. 2019 May;201(5):929-936. doi: 10.1016/j.juro.2018.10.018.
2
Variation in Guideline Concordant Active Surveillance Followup in Diverse Urology Practices.不同泌尿外科实践中指南一致的主动监测随访的差异。
J Urol. 2017 Mar;197(3 Pt 1):621-626. doi: 10.1016/j.juro.2016.09.071. Epub 2016 Sep 20.
3
Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer.密歇根州低危前列腺癌男性中初始主动监测的当代应用。
Eur Urol. 2015 Jan;67(1):44-50. doi: 10.1016/j.eururo.2014.08.024. Epub 2014 Aug 24.
4
Concordance of confirmatory prostate biopsy in active surveillance with national guidelines: An analysis from the multi-institutional PURC cohort.国家指南指导下主动监测中确认性前列腺活检的一致性:多机构 PURC 队列分析。
Urol Oncol. 2020 Nov;38(11):846.e17-846.e22. doi: 10.1016/j.urolonc.2020.07.008. Epub 2020 Jul 29.
5
Appropriateness Criteria for Active Surveillance of Prostate Cancer.前列腺癌主动监测的适宜性标准。
J Urol. 2017 Jan;197(1):67-74. doi: 10.1016/j.juro.2016.07.005. Epub 2016 Jul 14.
6
Outcomes of Active Surveillance after Initial Surveillance Prostate Biopsy.初始前列腺活检后主动监测的结果。
J Urol. 2017 Jan;197(1):84-89. doi: 10.1016/j.juro.2016.07.072. Epub 2016 Jul 20.
7
Biopsy features associated with prostate cancer progression in active surveillance patients: comparison of three statistical models.主动监测患者中与前列腺癌进展相关的活检特征:三种统计模型的比较。
BJU Int. 2013 Apr;111(4):574-9. doi: 10.1111/j.1464-410X.2012.11127.x. Epub 2012 May 4.
8
Factors Influencing Selection of Active Surveillance for Localized Prostate Cancer.影响局限性前列腺癌主动监测选择的因素。
Urology. 2015 Nov;86(5):901-5. doi: 10.1016/j.urology.2015.08.024. Epub 2015 Sep 7.
9
Active surveillance of prostate cancer: a questionnaire survey of urologists, clinical oncologists and urology nurse specialists across three cancer networks in the United Kingdom.前列腺癌的主动监测:对英国三个癌症网络的泌尿科医生、临床肿瘤学家和泌尿外科护士专家的问卷调查
BMC Urol. 2015 Jun 13;15:52. doi: 10.1186/s12894-015-0049-y.
10
What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database.新诊断前列腺癌患者中适合进行监测的比例是多少?对CaPSURE数据库的分析。
J Urol. 2008 Oct;180(4):1330-4; discussion 1334-5. doi: 10.1016/j.juro.2008.06.019. Epub 2008 Aug 15.

引用本文的文献

1
Active surveillance selection and 3-year durability in intermediate-risk prostate cancer following genomic testing.基因组检测后中危前列腺癌的主动监测选择及3年耐久性
Prostate Cancer Prostatic Dis. 2024 Sep 5. doi: 10.1038/s41391-024-00888-y.
2
Non-invasively identifying candidates of active surveillance for prostate cancer using magnetic resonance imaging radiomics.使用磁共振成像放射组学非侵入性地识别前列腺癌主动监测的候选者。
Vis Comput Ind Biomed Art. 2024 Jul 5;7(1):16. doi: 10.1186/s42492-024-00167-6.
3
The past, present, and future of urological quality improvement collaboratives.
泌尿外科质量改进协作组织的过去、现在与未来。
Transl Androl Urol. 2021 May;10(5):2280-2288. doi: 10.21037/tau.2019.10.18.